1 Zhao, C. L. et al. Pathological findings in the postmortem liver of patients with coronavirus disease 2019 (COVID-19). Hum Pathol 109, 59-68, doi:10.1016/j.humpath.2020.11.015 (2021).
2 Martines, R. B. et al. Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States. Emerg Infect Dis 26, 2005-2015, doi:10.3201/eid2609.202095 (2020).
3 Deshmukh, V., Motwani, R., Kumar, A., Kumari, C. & Raza, K. Histopathological observations in COVID-19: a systematic review. J Clin Pathol 74, 76-83, doi:10.1136/jclinpath-2020-206995 (2021).
4 Braxton, A. M. et al. Hamsters as a Model of Severe Acute Respiratory Syndrome Coronavirus-2. Comp Med, doi:10.30802/aalas-cm-21-000036 (2021).
5 Ogando, N. S. et al. SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology. J Gen Virol 101, 925-940, doi:10.1099/jgv.0.001453 (2020).
6 Joens, M. S. et al. Helium Ion Microscopy (HIM) for the imaging of biological samples at sub-nanometer resolution. Sci Rep 3, 3514, doi:10.1038/srep03514 (2013).
7 Bullock, H. A., Goldsmith, C. S. & Miller, S. E. Best practices for correctly identifying coronavirus by transmission electron microscopy. Kidney Int 99, 824-827, doi:10.1016/j.kint.2021.01.004 (2021).
8 Fan, Y. J., Chan, K. H. & Hung, I. F. Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Different Vaccines at Phase 3. Vaccines (Basel) 9, doi:10.3390/vaccines9090989 (2021).
9 Roback, J. D. & Guarner, J. Convalescent Plasma to Treat COVID-19: Possibilities and Challenges. Jama 323, 1561-1562, doi:10.1001/jama.2020.4940 (2020).
10 Weinreich, D. M. et al. REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19. N Engl J Med 384, 238-251, doi:10.1056/NEJMoa2035002 (2021).
11 McMillan, P., Dexhiemer, T., Neubig, R. R. & Uhal, B. D. COVID-19-A Theory of Autoimmunity Against ACE-2 Explained. Front Immunol 12, 582166, doi:10.3389/fimmu.2021.582166 (2021).
12 Kim, W. Y., Kweon, O. J., Cha, M. J., Baek, M. S. & Choi, S. H. Dexamethasone may improve severe COVID-19 via ameliorating endothelial injury and inflammation: A preliminary pilot study. PLoS One 16, e0254167, doi:10.1371/journal.pone.0254167 (2021).
13 Ruiz-Rodríguez, J. C., Molnar, Z., Deliargyris, E. N. & Ferrer, R. The Use of CytoSorb Therapy in Critically Ill COVID-19 Patients: Review of the Rationale and Current Clinical Experiences. Crit Care Res Pract 2021, 7769516, doi:10.1155/2021/7769516 (2021).
14 Bergwerk, M. et al. Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. N Engl J Med, doi:10.1056/NEJMoa2109072 (2021).
15 Bahl, A. et al. Vaccination reduces need for emergency care in breakthrough COVID-19 infections: A multicenter cohort study. Lancet Reg Health Am, 100065, doi:10.1016/j.lana.2021.100065 (2021).
16 Bouhaddou, M. et al. The Global Phosphorylation Landscape of SARS-CoV-2 Infection. Cell 182, 685-712.e619, doi:10.1016/j.cell.2020.06.034 (2020).
17 Barreto-Vieira, D. F. et al. Morphology and morphogenesis of SARS-CoV-2 in Vero-E6 cells. Mem Inst Oswaldo Cruz 116, e200443, doi:10.1590/0074-02760200443 (2021).
18 Nassoy, P. & Lamaze, C. Stressing caveolae new role in cell mechanics. Trends Cell Biol 22, 381-389, doi:10.1016/j.tcb.2012.04.007 (2012).
19 Schürmann, M. et al. Helium Ion Microscopy Visualizes Lipid Nanodomains in Mammalian Cells. Small 11, 5781-5789, doi:10.1002/smll.201501540 (2015).
20 van Niel, G., D'Angelo, G. & Raposo, G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol 19, 213-228, doi:10.1038/nrm.2017.125 (2018).
21 Chatterjee, V., Yang, X., Ma, Y., Wu, M. H. & Yuan, S. Y. Extracellular vesicles: new players in regulating vascular barrier function. Am J Physiol Heart Circ Physiol 319, H1181-h1196, doi:10.1152/ajpheart.00579.2020 (2020).
22 Gurke, S., Barroso, J. F. & Gerdes, H. H. The art of cellular communication: tunneling nanotubes bridge the divide. Histochem Cell Biol 129, 539-550, doi:10.1007/s00418-008-0412-0 (2008).
23 Kimura, S., Hase, K. & Ohno, H. Tunneling nanotubes: emerging view of their molecular components and formation mechanisms. Exp Cell Res 318, 1699-1706, doi:10.1016/j.yexcr.2012.05.013 (2012).
24 Karlikow, M. et al. Drosophila cells use nanotube-like structures to transfer dsRNA and RNAi machinery between cells. Sci Rep 6, 27085, doi:10.1038/srep27085 (2016).
25 Zhang, S., Kazanietz, M. G. & Cooke, M. Rho GTPases and the emerging role of tunneling nanotubes in physiology and disease. Am J Physiol Cell Physiol 319, C877-c884, doi:10.1152/ajpcell.00351.2020 (2020).
26 Tiwari, V., Koganti, R., Russell, G., Sharma, A. & Shukla, D. Role of Tunneling Nanotubes in Viral Infection, Neurodegenerative Disease, and Cancer. Front Immunol 12, 680891, doi:10.3389/fimmu.2021.680891 (2021).
27 Zhu, H. et al. Rab8a/Rab11a regulate intercellular communications between neural cells via tunneling nanotubes. Cell Death Dis 7, e2523, doi:10.1038/cddis.2016.441 (2016).
28 Rustom, A., Saffrich, R., Markovic, I., Walther, P. & Gerdes, H. H. Nanotubular highways for intercellular organelle transport. Science 303, 1007-1010, doi:10.1126/science.1093133 (2004).
29 Osswald, M. et al. Brain tumour cells interconnect to a functional and resistant network. Nature 528, 93-98, doi:10.1038/nature16071 (2015).
30 Eugenin, E. A., Gaskill, P. J. & Berman, J. W. Tunneling nanotubes (TNT) are induced by HIV-infection of macrophages: a potential mechanism for intercellular HIV trafficking. Cell Immunol 254, 142-148, doi:10.1016/j.cellimm.2008.08.005 (2009).
31 Kumar, A. et al. Influenza virus exploits tunneling nanotubes for cell-to-cell spread. Sci Rep 7, 40360, doi:10.1038/srep40360 (2017).
32 Gousset, K. & Zurzolo, C. Tunnelling nanotubes: a highway for prion spreading? Prion 3, 94-98, doi:10.4161/pri.3.2.8917 (2009).
33 Bloemendal, S. & Kück, U. Cell-to-cell communication in plants, animals, and fungi: a comparative review. Naturwissenschaften 100, 3-19, doi:10.1007/s00114-012-0988-z (2013).
34 Kim, B. W., Lee, J. S. & Ko, Y. G. Mycoplasma exploits mammalian tunneling nanotubes for cell-to-cell dissemination. BMB Rep 52, 490-495, doi:10.5483/BMBRep.2019.52.8.243 (2019).
35 Vignais, M. L., Caicedo, A., Brondello, J. M. & Jorgensen, C. Cell Connections by Tunneling Nanotubes: Effects of Mitochondrial Trafficking on Target Cell Metabolism, Homeostasis, and Response to Therapy. Stem Cells Int 2017, 6917941, doi:10.1155/2017/6917941 (2017).
36 Sherer, N. M. & Mothes, W. Cytonemes and tunneling nanotubules in cell-cell communication and viral pathogenesis. Trends Cell Biol 18, 414-420, doi:10.1016/j.tcb.2008.07.003 (2008).
37 Abounit, S. & Zurzolo, C. Wiring through tunneling nanotubes--from electrical signals to organelle transfer. J Cell Sci 125, 1089-1098, doi:10.1242/jcs.083279 (2012).
38 Ramírez-Weber, F. A. & Kornberg, T. B. Cytonemes: cellular processes that project to the principal signaling center in Drosophila imaginal discs. Cell 97, 599-607, doi:10.1016/s0092-8674(00)80771-0 (1999).
39 Nussenzveig, H. M. Are cell membrane nanotubes the ancestors of the nervous system? Eur Biophys J 48, 593-598, doi:10.1007/s00249-019-01388-x (2019).
40 Martínez-Calvo, A., Rivero-Rodríguez, J., Scheid, B. & Sevilla, A. Natural break-up and satellite formation regimes of surfactant-laden liquid threads. Journal of Fluid Mechanics 883, A35, doi:10.1017/jfm.2019.874 (2020).
41 Leroy, H. et al. Virus-Mediated Cell-Cell Fusion. Int J Mol Sci 21, doi:10.3390/ijms21249644 (2020).
42 Lin, L., Li, Q., Wang, Y. & Shi, Y. Syncytia formation during SARS-CoV-2 lung infection: a disastrous unity to eliminate lymphocytes. Cell Death Differ 28, 2019-2021, doi:10.1038/s41418-021-00795-y (2021).
43 Zhang, Z. et al. SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination. Cell Death Differ 28, 2765-2777, doi:10.1038/s41418-021-00782-3 (2021).
44 Braga, L. et al. Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia. Nature 594, 88-93, doi:10.1038/s41586-021-03491-6 (2021).
45 Colombo, M., Raposo, G. & Théry, C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 30, 255-289, doi:10.1146/annurev-cellbio-101512-122326 (2014).
46 Nolte-'t Hoen, E., Cremer, T., Gallo, R. C. & Margolis, L. B. Extracellular vesicles and viruses: Are they close relatives? Proc Natl Acad Sci U S A 113, 9155-9161, doi:10.1073/pnas.1605146113 (2016).
47 Schorey, J. S. & Harding, C. V. Extracellular vesicles and infectious diseases: new complexity to an old story. J Clin Invest 126, 1181-1189, doi:10.1172/jci81132 (2016).
48 Urbanelli, L. et al. The Role of Extracellular Vesicles in Viral Infection and Transmission. Vaccines (Basel) 7, doi:10.3390/vaccines7030102 (2019).
49 Kadiu, I., Narayanasamy, P., Dash, P. K., Zhang, W. & Gendelman, H. E. Biochemical and biologic characterization of exosomes and microvesicles as facilitators of HIV-1 infection in macrophages. J Immunol 189, 744-754, doi:10.4049/jimmunol.1102244 (2012).
50 Gould, S. J., Booth, A. M. & Hildreth, J. E. The Trojan exosome hypothesis. Proc Natl Acad Sci U S A 100, 10592-10597, doi:10.1073/pnas.1831413100 (2003).
51 Hildreth, J. E. K. HIV As Trojan Exosome: Immunological Paradox Explained? Front Immunol 8, 1715, doi:10.3389/fimmu.2017.01715 (2017).
52 Elrashdy, F., Aljaddawi, A. A., Redwan, E. M. & Uversky, V. N. On the potential role of exosomes in the COVID-19 reinfection/reactivation opportunity. J Biomol Struct Dyn, 1-12, doi:10.1080/07391102.2020.1790426 (2020).
53 Rosell, A. et al. Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality. Arterioscler Thromb Vasc Biol 41, Atvbaha120315547, doi:10.1161/atvbaha.120.315547 (2020).
54 Guervilly, C. et al. Dissemination of extreme levels of extracellular vesicles: tissue factor activity in patients with severe COVID-19. Blood Adv 5, 628-634, doi:10.1182/bloodadvances.2020003308 (2021).
55 Sur, S. et al. Exosomes from COVID-19 Patients Carry Tenascin-C and Fibrinogen-β in Triggering Inflammatory Signals in Cells of Distant Organ. Int J Mol Sci 22, doi:10.3390/ijms22063184 (2021).
56 Cappellano, G. et al. Circulating Platelet-Derived Extracellular Vesicles Are a Hallmark of Sars-Cov-2 Infection. Cells 10, doi:10.3390/cells10010085 (2021).
57 Barberis, E. et al. Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection. Front Mol Biosci 8, 632290, doi:10.3389/fmolb.2021.632290 (2021).
58 Ke, Z. et al. Structures and distributions of SARS-CoV-2 spike proteins on intact virions. Nature 588, 498-502, doi:10.1038/s41586-020-2665-2 (2020).
59 Laue, M. et al. Morphometry of SARS-CoV and SARS-CoV-2 particles in ultrathin plastic sections of infected Vero cell cultures. Sci Rep 11, 3515, doi:10.1038/s41598-021-82852-7 (2021).
60 Knack, R. S., Losso, L. C., Knack, R. S. & Hanada, T. Preliminary results of clinical use of colchicine in COVID-19 treatment. BMJ Case Rep 14, doi:10.1136/bcr-2021-244482 (2021).
61 Lien, C. H. et al. Repurposing Colchicine in Treating Patients with COVID-19: A Systematic Review and Meta-Analysis. Life (Basel) 11, doi:10.3390/life11080864 (2021).
62 Vincent, M. J. et al. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J 2, 69, doi:10.1186/1743-422x-2-69 (2005).
63 Derwand, R. & Scholz, M. Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19? Med Hypotheses 142, 109815, doi:10.1016/j.mehy.2020.109815 (2020).
64 Wirtz, T., De Castro, O., Audinot, J. N. & Philipp, P. Imaging and Analytics on the Helium Ion Microscope. Annu Rev Anal Chem (Palo Alto Calif) 12, 523-543, doi:10.1146/annurev-anchem-061318-115457 (2019).
65 Schmidt, M., Byrne, J. M. & Maasilta, I. J. Bio-imaging with the helium-ion microscope: A review. Beilstein J Nanotechnol 12, 1-23, doi:10.3762/bjnano.12.1 (2021).
66 Takayama, K. In Vitro and Animal Models for SARS-CoV-2 research. Trends Pharmacol Sci 41, 513-517, doi:10.1016/j.tips.2020.05.005 (2020).
67 Desmyter, J., Melnick, J. L. & Rawls, W. E. Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero). J Virol 2, 955-961, doi:10.1128/jvi.2.10.955-961.1968 (1968).
68 Xie, X. et al. An Infectious cDNA Clone of SARS-CoV-2. Cell Host Microbe 27, 841-848.e843, doi:10.1016/j.chom.2020.04.004 (2020).
69 Kumar, R., Kolloli, A. & Subbian, S. Inactivation and Elimination of SARS-CoV-2 in Biosamples Using Simple Fixatives and Ultrafiltration. Methods Protoc 4, doi:10.3390/mps4010018 (2021).
70 Shaner, N. C. et al. A bright monomeric green fluorescent protein derived from Branchiostoma lanceolatum. Nat Methods 10, 407-409, doi:10.1038/nmeth.2413 (2013).